Here are relevant reports on : biopharmaceutical
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Excipients Market - Global Forecast to 2029
The global biopharmaceutical excipients market accounted for USD XX billion in 2023. It is projected to reach USD XX billion by 2029 from USD XX billion in 2024, at a CAGR of XX% during the forecast period.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Strategic Analysis & Forecast of US Biopharmaceutical Industry – (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market
The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Israel Biopharmaceutical Research and Development Market - Global Trends and Forecast to 2020
In this report, the Israel biopharmaceutical R&D market is broadly segmented by products & services and end user. On the basis of products and services, the Israel biopharmaceutical R&D market is segmented into five broad categories, namely, instruments, consumables, bioreactors, services, and software. The instruments segment is further segmented into separation instruments, detection and screening instruments, imaging instruments, automation and high-throughput screening instruments, and others. Likewise, the consumables segment is divided into assays kits and reagents, cell culture media, cell lines, microplates, and others; while, the bioreactors segment is further classified into stainless steel bioreactors and single-use bioreactors.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Nanoparticle Analysis Market by Technology (DLS, NTA, XRD, SMPS, CPC, NSAM), Analysis Type (Size, Zeta Potential, Weight, Flow properties), End-user (Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutions) - Global Forecast to 2020
This report studies the global nanoparticle analysis market over the forecast period of 2015 to 2020. The market is expected to reach USD 91.1 Million by 2020, at CAGR of 5.4% from 2015 to 2020. Rising focus on nanotechnology research, continuous advancements in nanoparticle analysis technologies, and increasing government spending on pharmaceutical R&D in emerging nations are key factors fuelling the growth of the nanoparticle analysis market. Increasing demand for customized medical implants, requirement of less sample volume and sample preparation in advanced analytical technologies, and stringent regulatory guidelines for drug approval are some other prime factors offering growth opportunities for players in the nanoparticle analysis market. However, high cost of nanoparticle analysis instruments is one of the key restraints for the market growth.
- Published: November 2015
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market Size by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), and End User - Global Forecast to 2029
The global biopharmaceutical process analytical technology market, valued at US$1.0 billion in 2023, stood at US$1.2 billion in 2024 and is projected to advance at a resilient CAGR of 16.0% from 2024 to 2029, culminating in a forecasted valuation of US$2.6 billion by the end of the period. The market is witnessing a surge in growth propelled by rising investments, both direct and indirect, in analytical instruments, coupled with strategic partnerships aimed at advancing drug discovery.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
High Throughput Process Development Market by Product (Consumables (Minicolumn, Mini Bioreactor), Instruments), Services, Software, Molecule Type (mAB), Technology (Affinity Chromatography), End User (Biopharmaceutical) - Global Forecast to 2021
The global high throughput process development market is expected to reach USD 415.5 Million in 2021 from USD 212.1 Million in 2016, at a CAGR of 14.4% from 2016 to 2021. Major players operating in the high throughput process development market include Danaher (US), GE Healthcare (US), Agilent Technologies (US), Merck Millipore (Germany), and Thermo Fisher Scientific (US).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Filter Integrity Test Market by Test Type (Bubble Point, Diffusion, Water Flow), Mechanism (Manual, Automation), Filter Type (Air, Liquid), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, Academics) - Global Forecast to 2024
The Filter Integrity Test Market is projected to reach USD 79 million by 2024, growing at a CAGR of 5.0%. Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the filter integrity test market. The major players in the filter integrity test market are Merck KGaA (Germany), Danaher Corporation/Pall Corporation (US), Sartorius (Germany), Donaldson Company (US), Parker Hannifin Corporation (US), Meissner Filtration Product (US), MDI Filtration Technologies (US), Thermo Fisher Scientific (US), Eaton Corporation (Ireland), and SH-Surway (China).
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Stable Isotope Labeled Compounds Market by Type (Carbon 13, D, Oxygen 18, N15), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical & Biopharmaceutical Companies, Academic institute), Region – Global Forecast to 2024
The global stable isotope labeled compounds market in terms of revenue was estimated to be worth $269 million in 2019 and is poised to reach $312 million by 2024, growing at a CAGR of 3.0% from 2019 to 2024. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: January 2020
- Price: $ 4950
- TOC Available:
-
PVDF Membrane Market by Technology, Type (Hydrophobic, Hydrophilic), Application (General Filtration, Sample Preparation, Bead – Based Assays), End-Use Industry (Biopharmaceutical, Industrial, Food & Beverage), and Region - Global Forecast to 2027
The PVDF membrane market is expected to grow from USD 779 million in 2022 to USD 1,126 million by 2027, at a CAGR of 7.7% during the forecast period. The key players in this market are Arkema S.A. (France), Merck Millipore (US), KOCH Separation Solutions (US), Pall Corporation (US), Cytiva Life Science (US), CITIC Envirotech Pte Ltd (Singapore), Bio-Rad laboratories (US), Thermo Fisher Scientific Inc. (US), Membrane Solutions, LLC. (US), GVS Filter Technology (Italy), and Toray Industries, Inc. (Japan).
- Published: January 2023
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 21
